C Ann Merrifield - Net Worth and Insider Trading
C Ann Merrifield Net Worth
The estimated net worth of C Ann Merrifield is at least $319,388 dollars as of 2024-04-26. C Ann Merrifield is the Director of Juniper Pharmaceuticals Inc and owns about 15,193 shares of Juniper Pharmaceuticals Inc (JNP) stock worth over $174,720. C Ann Merrifield is the Director of Flexion Therapeutics Inc and owns about 10,000 shares of Flexion Therapeutics Inc (FLXN) stock worth over $91,200. C Ann Merrifield is also the Director of Lyra Therapeutics Inc and owns about 11,328 shares of Lyra Therapeutics Inc (LYRA) stock worth over $53,468. Besides these, C Ann Merrifield also holds InVivo Therapeutics Holdings Corp (NVIVQ) . Details can be seen in C Ann Merrifield's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that C Ann Merrifield has not made any transactions after 2022-06-10 and currently still holds the listed stock(s).
Transaction Summary of C Ann Merrifield
C Ann Merrifield Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, C Ann Merrifield owns 4 companies in total, including Flexion Therapeutics Inc (FLXN) , Lyra Therapeutics Inc (LYRA) , and InVivo Therapeutics Holdings Corp (NVIVQ) among others .
Click here to see the complete history of C Ann Merrifield’s form 4 insider trades.
Insider Ownership Summary of C Ann Merrifield
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| FLXN | Flexion Therapeutics Inc | 2020-06-10 | director |
| LYRA | Lyra Therapeutics Inc | 2022-06-10 | director |
| NVIVQ | InVivo Therapeutics Holdings Corp | 2022-11-17 | director |
| JNP | Juniper Pharmaceuticals Inc | 2018-08-14 | director |
C Ann Merrifield Latest Holdings Summary
C Ann Merrifield currently owns a total of 4 stocks. Among these stocks, C Ann Merrifield owns 15,193 shares of Juniper Pharmaceuticals Inc (JNP) as of August 26, 2016, with a value of $174,720 and a weighting of 54.7%. C Ann Merrifield owns 10,000 shares of Flexion Therapeutics Inc (FLXN) as of May 23, 2019, with a value of $91,200 and a weighting of 28.55%. C Ann Merrifield also owns 11,328 shares of Lyra Therapeutics Inc (LYRA) as of June 10, 2022, with a value of $53,468 and a weighting of 16.74%. The other 1 stocks InVivo Therapeutics Holdings Corp (NVIVQ) have a combined weighting of 0% among all his current holdings.
Latest Holdings of C Ann Merrifield
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| JNP | Juniper Pharmaceuticals Inc | 2016-08-26 | 15,193 | 11.50 | 174,720 |
| FLXN | Flexion Therapeutics Inc | 2019-05-23 | 10,000 | 9.12 | 91,200 |
| LYRA | Lyra Therapeutics Inc | 2022-06-10 | 11,328 | 4.72 | 53,468 |
| NVIVQ | InVivo Therapeutics Holdings Corp | 2015-08-12 | 0 | 0.37 | 0 |
Holding Weightings of C Ann Merrifield
C Ann Merrifield Form 4 Trading Tracker
According to the SEC Form 4 filings, C Ann Merrifield has made a total of 0 transactions in Juniper Pharmaceuticals Inc (JNP) over the past 5 years. The most-recent trade in Juniper Pharmaceuticals Inc is the acquisition of 2,000 shares on August 26, 2016, which cost C Ann Merrifield around $11,260.
According to the SEC Form 4 filings, C Ann Merrifield has made a total of 1 transactions in Flexion Therapeutics Inc (FLXN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Flexion Therapeutics Inc is the acquisition of 8,000 shares on May 23, 2019, which cost C Ann Merrifield around $101,120.
According to the SEC Form 4 filings, C Ann Merrifield has made a total of 3 transactions in Lyra Therapeutics Inc (LYRA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Lyra Therapeutics Inc is the acquisition of 4,000 shares on June 10, 2022, which cost C Ann Merrifield around $20,200.
More details on C Ann Merrifield's insider transactions can be found in the Insider Trading History of C Ann Merrifield table.Insider Trading History of C Ann Merrifield
- 1
C Ann Merrifield Trading Performance
GuruFocus tracks the stock performance after each of C Ann Merrifield's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by C Ann Merrifield is -3.45%. GuruFocus also compares C Ann Merrifield's trading performance to market benchmark return within the same time period. The performance of stocks bought by C Ann Merrifield within 3 months outperforms 4 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how C Ann Merrifield's insider trading performs compared to the benchmark.
Performance of C Ann Merrifield
Average Return
-31.49%
Outperforming Transactions
10%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.46 | -3.45 | -24.56 | -31.49 | -14.15 | -21.41 |
| Relative Return to S&P 500(%) | -0.27 | -4.96 | -26.47 | -37.19 | -26.18 | -33.12 |
C Ann Merrifield Ownership Network
Ownership Network List of C Ann Merrifield
Ownership Network Relation of C Ann Merrifield
C Ann Merrifield Owned Company Details
What does Flexion Therapeutics Inc do?
Who are the key executives at Flexion Therapeutics Inc?
C Ann Merrifield is the director of Flexion Therapeutics Inc. Other key executives at Flexion Therapeutics Inc include Chief Regulatory Officer Kerry Wentworth , General Counsel Mark S. Levine , and Chief Strategy Officer Christina Willwerth .
Flexion Therapeutics Inc (FLXN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Flexion Therapeutics Inc (FLXN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Flexion Therapeutics Inc (FLXN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Flexion Therapeutics Inc (FLXN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Flexion Therapeutics Inc Insider Transactions
C Ann Merrifield Mailing Address
Above is the net worth, insider trading, and ownership report for C Ann Merrifield. Currently GuruFocus does not have mailing address information for C Ann Merrifield.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
